News
The state registration of the combined medicine VivaCor® has been completed
28 DecemberVIVA Pharm company informs about the completion of registration of the combined medicine VIVACOR®, tablets, 5/5 mg (RK-LS-5№023443), 5/10 mg (RK-LS-5№023444), 10/20 mg (RK-LS-5№023445).
VIVACOR® refers to the pharmacotherapeutic group of ACE inhibitors in combination with calcium channel blocking agents. Active substances: lisinopril and amlodipine.
